Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Autonomix Medical, Inc. develops advanced catheter-based medical devices for sensing and treating peripheral nervous system disorders. Its proprietary microchip-enabled sensing array detects low-voltage neural signals with high precision, enabling targeted radiofrequency ablation therapies. Initially focused on managing pancreatic cancer pain, the technology platform aims to address broader indications including chronic pain, hypertension, and other nerve-related conditions. The company’s business model centers on disposable catheters and software solutions for hospital catheter labs.
This description was generated via AI from an annual report. Updated about 1 year ago.